Nina Jones Selected Research

Eczema

12/2013

Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nina Jones Research Topics

Disease

7	Proteinuria 01/2022 - 01/2011
3	Infections 01/2020 - 09/2010
2	Neoplasms (Cancer) 02/2021 - 01/2018
2	Glioma (Gliomas) 02/2021 - 01/2021
2	Immediate Hypersensitivity 01/2019 - 01/2016
2	Inflammation (Inflammations) 11/2018 - 10/2016
2	Atopic Dermatitis (Atopic Eczema) 08/2017 - 12/2013
2	Anaphylaxis (Anaphylactic Shock) 01/2016 - 12/2013
2	Job Syndrome (Hyper-IgE Syndrome) 01/2016 - 12/2013
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 02/2021
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2018
1	Osteosarcoma (Osteogenic Sarcoma) 01/2018
1	Flushing 12/2016
1	Joint Instability (Joint Laxity) 12/2016
1	Pruritus (Itching) 12/2016
1	Chronic Pain 12/2016
1	Autonomic Nervous System Diseases (Dysautonomia) 12/2016
1	Wiskott-Aldrich Syndrome 10/2016
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2015
1	type 2C Congenital disorder of glycosylation 12/2013
1	Eczema 12/2013
1	Severe combined immunodeficiency due to adenosine deaminase deficiency 12/2013
1	Food Hypersensitivity (Food Allergy) 12/2013
1	Paraproteinemias (Monoclonal Gammopathy) 05/2012
1	Albuminuria 09/2011
1	Nephrosis 01/2011
1	Skin Abnormalities 03/2005
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2005

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2011
6	nephrinIBA 01/2022 - 01/2012
5	Immunoglobulin E (IgE)IBA 01/2019 - 12/2013
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2021 - 03/2005
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2015
2	PhosphotyrosineIBA 01/2021 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2021 - 09/2011
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2016 - 12/2013
1	Phytoestrogens (Phytoestrogen)IBA 01/2022
1	daidzeinIBA 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 02/2021
1	Phosphotransferases (Kinase)IBA 02/2021
1	TIE-2 Receptor (Receptor, TIE 2)IBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	Actins (F Actin)IBA 01/2020
1	Toll-Like Receptor 4IBA 11/2018
1	LipopolysaccharidesIBA 11/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Biotin (Vitamin H)FDA Link 01/2018
1	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2018
1	Tryptases (Tryptase)IBA 12/2016
1	AllergensIBA 10/2016
1	Histamine Receptors (Histamine Receptor)IBA 01/2016
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2016
1	Morphine (MS Contin)FDA LinkGeneric 12/2013
1	GTP Phosphohydrolases (GTPases)IBA 07/2012
1	Immunoglobulins (Immunoglobulin)IBA 05/2012
1	CollagenIBA 09/2011
1	Fibronectins (Fibronectin)IBA 09/2011
1	Doxycycline (Periostat)FDA LinkGeneric 09/2011
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2011
1	Puromycin AminonucleosideIBA 01/2011
1	Cre recombinaseIBA 09/2010
1	Angiopoietin-2IBA 03/2005
1	Angiopoietin-1IBA 03/2005
1	AngiopoietinsIBA 03/2005
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2005
1	Tetracycline (Achromycin)FDA LinkGeneric 03/2005

Therapy/Procedure

3	Therapeutics 02/2021 - 01/2018
1	Precision Medicine 01/2018